Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obstacles and advances in SARS vaccine development.

Deborah R Taylor1

  • 1Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration, Bethesda, MD 20892, USA. taylord@cber.fda.gov

Vaccine
|September 30, 2005
PubMed
Summary

Developing vaccines for severe acute respiratory syndrome (SARS) faced challenges due to knowledge gaps in viral pathogenesis and limitations in animal models. Overcoming these obstacles is crucial for future pandemic preparedness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HCV-Mediated Apoptosis of Hepatocytes in Culture and Viral Pathogenesis.

PloS one·2016
Same author

The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update.

Journal of women's health (2002)·2016
Same author

A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.

PloS one·2016
Same author

Rapid detection of hepatitis B virus in blood plasma by a specific and sensitive loop-mediated isothermal amplification assay.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2014
Same author

Evolution of cell culture systems for HCV.

Antiviral therapy·2013
Same author

Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture.

International journal of biomedical science : IJBS·2013

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • The 2003 severe acute respiratory syndrome (SARS) pandemic highlighted the urgent need for effective vaccines.
  • Global scientific collaboration accelerated early research efforts in response to the public health crisis.

Purpose of the Study:

  • To review the progress and identify the challenges in developing vaccines against SARS-CoV.
  • To discuss the hurdles faced by researchers and regulatory bodies in vaccine development.

Main Methods:

  • Literature review of SARS vaccine development efforts.
  • Analysis of existing knowledge gaps in viral pathogenesis.
  • Evaluation of animal models for SARS research.

Main Results:

Related Experiment Videos

  • Significant advances in animal models for SARS, but concerns remain regarding their pathological relevance to human disease.
  • Identification of substantial gaps in understanding the pathogenesis of the SARS virus.
  • Progress in vaccine development is ongoing but faces considerable obstacles.

Conclusions:

  • Further research is needed to address knowledge gaps in SARS pathogenesis.
  • Improvements in animal models are required for better preclinical evaluation of vaccines.
  • Regulatory agencies and researchers must collaborate to overcome challenges in vaccine development and deployment.